A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas
A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas
Recruiting · NCT06219356 · Registry updated 2025-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma | Recruiting | Phase 1 | 2025-08-19 | NCT06219356 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hangzhou GluBio Pharmaceutical Co., Ltd. | 2 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |
| Fudan University Shanghai Cancer Center | Shanghai | China | 257 |
| Henan Cancer Hospital | Zhengzhou | China | 57 |
| Hunan Cancer Hospital | Changsha | China | 41 |
| Jiangxi Cancer Hospital | Nanchang | China | 48 |
| Peking University Third Hospital | Beijing | China | 123 |
| Shanxi Cancer Hospital | Taiyuan | China | 24 |
| Shengjing Hospital Of China Medical University | Shenyang | China | 54 |
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |
| The First Affiliated hospital of Xiamen University | Xiamen | China | 69 |
| The First Affilicated Hospital, Zhejiang University School of Medicine | Hangzhou | China | 2 |
| Tianjing Medical University Cancer Institute and Hospital | Tianjin | China | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 7 |